U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

OMILOXETINE

MORE DETAILS

  H8YI0SSF7B

Status:
Investigational
Source:
INN:omiloxetine
Source URL:
https://tripod.nih.gov/npc/#Download
Class (Stereo):
CHEMICAL (RACEMIC)
Omiloxetine, a serotonin uptake inhibitor was developed in Spain for the treatment of depression. However, in 2005, it was abandoned.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966